Imofinostat
Imofinostat is an investigational new drug that is being developed by Formosa Pharmaceuticals and Anbogen Therapeutics for the treatment of colorectal cancer.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Imofinostat is an investigational new drug that is being developed by Formosa Pharmaceuticals and Anbogen Therapeutics for the treatment of colorectal cancer. It is a histone deacetylase inhibitor with selectivity for HDAC3.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368216953 under CC BY-SA 4.0; modifications have been made.